TaiMed's Trogarzo Is US FDA's First HIV/AIDS Breakthrough Approval

Unusual review of ibalizumab-uiyk marks other HIV firsts too: first monoclonal antibody and first new mechanism of action in 10 years. Company considered several routes of administration, and the Phase III trial was actually smaller than the Phase II study.